Medical and healthcare innovation
Includes sessions on:
- A strategy for cancer in England over the next five years
- Precision Medicine: From Basic Discoveries to Prevention, Cure and Improved Health of our Nation
- Improving outcomes in patients with sepsis
- SBRI Healthcare – Bringing New Technologies to the NHS
9-10 October 2015
Innovate UK 2015, 9-10 October 2015, London. Hosted by Innovate UK and UKTI, this two-day event will bring together 3,000 of the UK’s most exciting innovators with investors, global corporates and the research base. This year, Innovate UK 2015 will be part of UKTI’s Export Week, a series of events aimed at businesses looking to start their export journey or investigate how to increase their international business.
15 October 2015
UK Bioscience Forum 2015, 15 October 2015, London. Hosted by the UK BioIndustry Association (BIA). The BIA continues to secure its position as a global for innovative research and commercialisation, enabling the UK’s world-leading research base to deliver healthcare solutions. The UK life sciences sector is at an exciting time, building on recent successes in biomedicine, flourishing with investment including some very successful IPOs.
Regional Innovation news
27 October 2015
Accelerated Access Review: interim report. Sir Hugh Taylor sets out 5 propositions to speed up access to transformative health technology that can change the lives of NHS patients. Also mentions that efforts to develop and spread the use of innovative drugs and technologies in the NHS could be threatened by ‘unprecedented’ funding pressure.
16 October 2015
CRISPR could make animal-to-human organ transplant safer. Harvard University researchers used the Crispr technique to alter the DNA of pig cells to create a better match for humans.
14 October 2015
14 October 2015
8-10 November 2015
28 September 2015
Article in The Pathologist The Uberification of Phlebotomy. A US company has created an on-demand phlebotomy service known as Iggbo. In eight months, Iggbo has reportedly attracted 4,000 phlebotomists, and is now operating in over 18 states, with plans to expand further.
24 September 2015
UK mhealth market value to reach £250m by 2018. The UK mobile health (mHealth) applications market is set to grow at a CAGR rate of 35% by 2018, according to a joint report from health watchdog Monitor and Deloitte.
14 September 2015
Cancer blood-test launch raises eyebrows. A US start-up called Pathway Genomics has launched the first commercial 'liquid biopsy' to identify cancerous mutations via a blood test. Pathway will market directly to healthy people who have a high risk of developing cancer and claim that they can help people achieve an early cancer diagnosis – for $699 (£450). For that money, the CancerIntercept test will look for 96 mutations in nine major cancer-driver genes whose presence could come from circulating tumour DNA, released from dying cancer cells.'It's like a cancer stethoscope,' explains the promotional video on Pathway's website. The test is not yet approved by the FDA and there is no peer-reviewed data provided to support their tests or technical approaches.
George Freeman, Minister for Life Sciences, explained how the NHS will make the most of research and innovation at the Health and Care Innovation Expo 2015 in Manchester. He spoke extensively about the role of genomics. In establishing a unique collaboration between NHS Genomic Medicine Centres, industry and academia for analysis of the genomic dataset, this project is also contributing to economic growth and establishing the UK as a leader in this sector. The aim is to grow the industry from £0.8 billion in 2015 to at least £1.2 billion in 2018.
4 September 2015
Encouraging early results of major 10,000 patient NHS Lung Cancer Screening Trial using EarlyCDT®-Lung test to be announced at the 16th World Conference on Lung Cancer. EarlyCDT®-Lung is a simple blood test which can be ordered by a GP to aid in the risk assessment and early detection of lung cancer. It has been developed to measure a panel of 7 autoantibodies associated specifically with lung cancer.
25 August 2015
Article in The Pathologist SMILE, It’s Easy “Secretary-mimicking” artificial intelligence could help lift the burden of tedious report preparation
- Voice recognition technology (VRT) and text to speech (TTS) enables a human-like interface with SMILE.
- Using its inbuilt knowledge, SMILE can respond to both verbal and non-verbal (slide scanning) actions by the user.
21 August 2015
Which universities are the most innovative? Data published by Times Higher Education this week in collaboration with Elsevier aim to shed new light on the world of university innovations and inventions by revealing which institutions show the strongest performance across four indicators: the ratio of papers co-authored with industry, the proportion of papers cited by patents, the quantity of research income from industry and the proportion of research income from industry. Institute of Cancer Research topped the highest number of patent citations. Please see also: Times Higher Education
17 August 2015
Pathobin universal smartphone microscope adapter. This is a universal smartphone microscope adapter 3D printed prototype.
17 August 2015
New sampling device promises to make blood tests needle-free using a device called HemoLink. HemoLink is designed as a low-cost, disposable device made from as few as six injection-moulded plastic parts. The device can draw, using capillary action, around 0.15 cubic centimetres of blood, which is enough to test for cholesterol, infections, cancer cells and blood sugar, before being mailed off to a lab for analysis.
11 August 2015
10 August 2015
Government funding for the next generation of medical advances has been announced by Minister for Life Sciences, George Freeman. The next generation of medical advances have moved a step closer thanks to £18m of government support. 12 new treatments, diagnostics and medical technologies will receive funding from the eighth round of the Biomedical Catalyst (BMC), a joint programme run by the MRC and the government’s innovation experts, Innovate UK.
10 August 2015
The UK BioIndustry Association (BIA) publishes a new report, The Biomedical Catalyst, making the case to continue. Published following the announcement of the last round of the current Biomedical Catalyst (BMC) funding allocation, the report gives a retrospective of the current scheme and showcases ten case studies from companies who have been recipients of BMC funding.
5 August 2015
4 August 2015
First 3D-printed pill approved by US authorities. The new drug, dubbed Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy.